Ondokuz Mayis University

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Mantle cell lymphoma1 trial
• Multiple myeloma1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials

Running trials

• Active, not recruiting

  A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma

  NCT05083169· Phase 3· Janssen Research & Development, LLC· Source

Closed trials

• Completed

  A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma

  NCT05564052· Phase 2· Janssen Research & Development, LLC· Source